JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a cash flow conversion efficiency ratio of -0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-934.42K) by net assets ($30.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of JIN MEDICAL INTERNATIONAL LTD. Ordinary for the company's overall valuation and market capitalisation.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their cash flow conversion efficiency. Explore ZJYL cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Molecular Partners AG
SW:MOLN
|
-0.099x |
|
Fu Chun Shin Machinery Manufacture Co Ltd
TWO:6603
|
0.029x |
|
Igarashi Motors India Limited
NSE:IGARASHI
|
0.099x |
|
Cegedim S.A.
PA:CGM
|
0.260x |
|
KHVATEC Co.Ltd
KQ:060720
|
0.116x |
|
LVMC Holdings
KO:900140
|
0.022x |
|
Tavia Acquisition Corp. Unit
NASDAQ:TAVIU
|
-0.001x |
|
Invesco Trust For Inv Grade NY Munis
NYSE:VTN
|
0.022x |
Annual Cash Flow Conversion Efficiency for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual cash flow conversion efficiency of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025. View JIN MEDICAL INTERNATIONAL LTD. Ordinary (ZJYL) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $29.57 Million | $2.90 Million | 0.098x | +332.21% |
| 2024-09-30 | $28.55 Million | $-1.21 Million | -0.042x | -132.64% |
| 2023-09-30 | $23.98 Million | $3.11 Million | 0.130x | +24.87% |
| 2022-09-30 | $15.24 Million | $1.58 Million | 0.104x | -75.09% |
| 2021-09-30 | $14.03 Million | $5.84 Million | 0.417x | +79.75% |
| 2020-09-30 | $10.80 Million | $2.50 Million | 0.232x | +287.15% |
| 2019-09-30 | $10.71 Million | $-1.33 Million | -0.124x | +53.45% |
| 2018-09-30 | $9.00 Million | $-2.39 Million | -0.266x | -- |
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more